Johannes Streffer
Keine laufenden Positionen mehr
Profil
Johannes Rolf Streffer worked as a Member-Alzheimer Disease Area at Janssen Pharmaceuticals, Inc. and as VP & Head-Translational Medicine Neuroscience at UCB Biopharma SRL.
He also served as Chief Medical Officer at AC Immune SA from 2021 to 2023.
Streffer completed his undergraduate degree at Eberhard Karls Universität Tübingen.
Ehemalige bekannte Positionen von Johannes Streffer
Unternehmen | Position | Ende |
---|---|---|
AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 30.09.2023 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The private company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Corporate Officer/Principal | - |
Ausbildung von Johannes Streffer
Eberhard Karls Universität Tübingen | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Private Unternehmen | 2 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The private company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting. | Distribution Services |